Cargando…
The Improvement in Hepatic Steatosis After Cushing’s Syndrome Treatment Is an Early Sign of Metabolic Recovery
Context: Cushing Syndrome (CS) is characterized by cortisol excess, impaired glucose tolerance, and obesity. As assessed by CT imaging, 20% of CS patients develop steatohepatitis (NASH). The gold standard test, liver biopsy, is associated with CS complications and cannot be used to confirm the diagn...
Autores principales: | Hamimi, Ahmed, Sater, Zahraa Abdul, McGlotten, Raven, Matta, Jatin, Pierce, Annie, Abd-elmoniem, Khaled, Ouwerkerk, Ronald, Nieman, Lynnette K, Gharib, Ahmed M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089667/ http://dx.doi.org/10.1210/jendso/bvab048.196 |
Ejemplares similares
-
SUN-368 Fatty Hypertrophy of the Hip as a Clinical Manifestation of Cushing Syndrome
por: McGlotten, Raven, et al.
Publicado: (2019) -
MON-167 Use of a Morning Cortisol Level to Predict Recovery of the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Secondary Adrenal Insufficiency Following Remission of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020) -
MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020) -
SUN-355 Computed Tomography Appearance of Adrenal Glands in Non-Adrenal Causes of Cushing's Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019) -
MON-162 Utility of 24-Hour Urine Cortisone for the Diagnosis of Cushing’s Syndrome
por: McGlotten, Raven, et al.
Publicado: (2020)